Leap Therapeutics Announces 1-For-10 Reverse Stock Split
Portfolio Pulse from Happy Mohamed
Leap Therapeutics (NASDAQ:LPTX) has announced a 1-for-10 reverse stock split, effective June 20, 2023, to meet Nasdaq's minimum listing price per share requirements and facilitate the conversion of Series X Non-Voting Convertible Preferred Stock into common stock.

June 20, 2023 | 4:35 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Leap Therapeutics' 1-for-10 reverse stock split aims to meet Nasdaq's minimum listing price requirements and facilitate Series X conversion.
The reverse stock split will increase the per-share trading price of LPTX, meeting Nasdaq's minimum listing price requirements. This action will also facilitate the conversion of Series X Non-Voting Convertible Preferred Stock into common stock. The impact on the stock price is neutral in the short term, as the split affects all shareholders uniformly and does not alter their percentage interest in the company's common stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100